THE E|D|C TEAM
Co-Founder | Chief Executive Officer
Co-Founder | Chief Operations Officer
With over 10 years of management experience, Nick has assisted in the resolution of various types of conflict and worked to establish multiple partnerships between researchers, labs, and companies.
Now, as part of the EDC group, he seeks to help solve the core management issues facing scientific institutions, from their faculty, down to their respective research support. By transforming the individual investigator into an efficient team leader we can continue fostering scientific curiosity and successfully realize the dream of discovery.
CATH ENNIS, PH.D.
Cath has a research background in genetics and has subsequently worked in diverse life sciences fields as a writer, editor, and project manager. She has also written popular science books about stem cell biology and epigenetics. She currently works as a freelance science writer and editor. https://cathennisconsulting.
Ji Hee Shin Etienne
Jonathan Thon, Ph.D.
Biotech Research Advisor
ELIZABETH KWO, MD, MBA
Business Management Advisor
BENJAMIN EBERT, MD, PH.D.
Academic Research Advisor
Dr. Ebert is an elected member of the American Society for Clinical Investigation and the Association of American Physicians, and he served as President of the American Society for Clinical Investigation. His awards include the Till and McCollough Award from the International Society of Experimental Hematopoiesis, the William Dameshek Prize from the American Society of Hematology, and mentoring and teaching awards from Harvard Medical School. He serves on the medical or scientific advisory boards of the Evans Foundation, Babich Foundation, MDS Foundation, the Aplastic Anemia and MDS Foundation, and the Stem Cell Institute at Cambridge University.
Dr. Ebert received a bachelor’s degree from Williams College, a doctorate from Oxford University as a Rhodes Scholar, and an M.D. from Harvard Medical School. He completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology/oncology at the Dana-Farber Cancer Institute. He was on the faculty of Brigham and Women’s Hospital for 10 years before returning to the Dana-Farber.